MWNA
CELL

Marshall Wace North America’s PhenomeX Inc. Common Stock CELL Stock Holding History

Marshall Wace North America’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1.1M Buy
56,083
+45,134
+412% +$1.72M ﹤0.01% 889
2021
Q2 		$491K Buy
+10,949
New +$508K ﹤0.01% 1180

Other funds holding CELL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Marshall Wace North America's CELL Position: Q3 2021 in Review

Marshall Wace North America increased its PhenomeX Inc. Common Stock (CELL) stake by 412% in Q3 2021, buying an estimated $1.72M and bringing the position to 56,083 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #889.

Marshall Wace North America first reported a position in CELL in Q2 2021 and has held it in 2 quarters since. 137 funds tracked by Wall St. Rank hold CELL as of Q3 2021.

  • Marshall Wace North America held 56,083 shares of PhenomeX Inc. Common Stock worth $1.1M as of Q3 2021.
  • Marshall Wace North America bought 45,134 PhenomeX Inc. Common Stock shares in Q3 2021, an estimated $1.72M.
  • PhenomeX Inc. Common Stock made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #889 holding.
  • Marshall Wace North America first reported a position in PhenomeX Inc. Common Stock in Q2 2021 and has held it in 2 quarters since.
  • 137 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.